Skip to main content
. 2000 Sep 12;97(20):10990–10995. doi: 10.1073/pnas.180329197

Figure 4.

Figure 4

PSA levels are modulated by troglitazone in prostate cancer patients. The PSA levels of prostate cancer patients, treated with 800 mg of troglitazone/day, were measured every 4 weeks. (A) The patient received radiation therapy in 11/94, nadir of 0.1. (B) Patient had post radiation therapy nadir of 1.9 on 6/2/94.